≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Insulin, intermediate and long-acting

PheWeb

INSULIN_INTER_AND_LONG

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC A10AE01|A10AE0[4-6]|A10AE30

19222

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

17800

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

17800

diagram downward connector

Include endpoints None

17800

diagram downward connector
INSULIN_INTER_AND_LONG

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 17800 7526 10274
Unadjusted prevalence (%) 5.00 3.79 6.53
Mean age at first event (years) 52.81 50.09 54.79

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.08 4.82 [3.93, 5.93] 1.3e-50 2647
15 years 0.02 2.74 [2.21, 3.40] 6.8e-20 1387
5 years 0.01 5.19 [4.38, 6.15] 3.4e-80 1096
1 year 0.00 3.29 [2.62, 4.13] 1.9e-24 134

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: INSULIN_INTER_AND_LONG – Insulin, intermediate and long-acting
GWS hits:

Survival analyses between endpoints

↥

Plot

before Insulin, intermediate and long-acting
after Insulin, intermediate and long-acting

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Insulin, intermediate and long-acting

↥